Dose Ranging Study of Dronedarone for the Control of Ventricular Rate in Japanese Patients With Permanent Atrial Fibrillation

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 181 participants.

Also called NCT01213368

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 181 participants (enrolled count) (from the registry)
Sponsor
  • Sanofi Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01213368
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01213368. Randomized; quadruple masking; primary purpose treatment. Start 2010-09 (registry gives no type); primary completion 2011-04 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Dose Ranging Study of Dronedarone for the Control of Ventricular Rate in Japanese Patients With Permanent Atrial Fibrillation
Intervention (Drug)
DRONEDARONE (SR33589)
Intervention (Drug)
placebo
Lead sponsor
Sanofi (class: industry)

Record details

Record id
cardio:ct-nct01213368
Content hash
753456190433c529b31aea94c46075da9c404c264922013eb9402ee3c3d2cc22